- EMCDDA >
- Data >
- Statistical archive >
- Statistical bulletin 2013 >
- Data >
- drdfig7a

Related links: | |||||
---|---|---|---|---|---|

Statistical bulletin 2008: Figure DRD-7 part (i) | |||||

Statistical bulletin 2009: Figure DRD-7 part (i) | |||||

Statistical bulletin 2010: Figure DRD-7 part (i) | |||||

Statistical bulletin 2011: Figure DRD-7 part (i) | |||||

Statistical bulletin 2012: Figure DRD-7 part (i) | |||||

See also 'General notes for interpreting data' on the Explanatory notes and help page. |

It is important to underline that simple comparisons of population rates should be made with caution since there are still differences in case definitions in a few countries and quality of reporting may differ across them.

The calculations of population mortality rates are based on 2011 population sizes as reported by Eurostat.

For Czech Republic, EMCDDA Selection D was used instead of the national definition.

For Greece data refers to the reported number of deaths.

For Austria the number of cases were no autopsy was performed in the official number of drug related deaths is included (201 instead of 177).

For Portugal the data is still provisional.

Due to the low number of drug-induced deaths in a year, three-year (Cyprus and Malta) averages were used. The results have been rounded to the nearest integral.

'n' refers to the total number of deaths (15 to 64 years).

Reitox national reports 2012, taken from national mortality registries or special registries (forensic or police). Based on ‘national definitions’ as presented in ‘Drug-related deaths — methods and definitions’.

Populations and total numbers of death for the EU countries are extracted from Eurostat, for the last year available.

Country | Rate DRD/million population 15–64 |

Romania (2011) (n = 15) | 1.0 |

Turkey (2011) (n = 93) | 1.9 |

Hungary (2011) (n = 14) | 2.0 |

Portugal (2011) (n = 19) | 2.7 |

Czech Republic (2011) (n = 28) | 3.8 |

Slovakia (2011) (n = 15) | 3.9 |

Bulgaria (2011) (n = 24) | 4.8 |

Latvia (2011) (n = 11) | 7.9 |

France (2010) (n = 331) | 7.9 |

Poland (2010) (n = 232) | 8.4 |

Netherlands (2011) (n = 101) | 9.1 |

Italy (2011) (n = 362) | 9.1 |

Greece (2011) (n = :) | 10.5 |

Spain (2010) (n = 392) | 12.5 |

Cyprus (2011) (n = 9.66) | 16.3 |

Slovenia (2011) (n = 24) | 16.9 |

Luxembourg (2011) (n = 6) | 17.1 |

Malta (2011) (n = 5) | 17.3 |

Germany (2011) (n = 966) | 17.9 |

Belgium (2008) (n = 142) | 19.6 |

Croatia (2011) (n = 59) | 19.8 |

Lithuania (2011) (n = 43) | 20.9 |

Austria (2011) (n = 201) | 35.3 |

Sweden (2011) (n = 217) | 35.5 |

Denmark (2010) (n = 181) | 49.8 |

Ireland (2010) (n = 159) | 51.8 |

United Kingdom (DSD) (2011) (n = 2153) | 52.3 |

Finland (2011) (n = 189) | 53.3 |

Norway (2010) (n = 238) | 73.1 |

Estonia (2011) (n = 123) | 135.7 |

drdfig7a

Demonstration | Reference | Type | Y Axis | X axis | Label | Width (%) | Height (px) | X plotline | Y plotline | Y min,max values | series Markers |
---|---|---|---|---|---|---|---|---|---|---|---|

szrfig1 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||

szrfig2 | column,column,line | Quantity (kg)|Number of seizures$3 | |||||||||

gpsfig4a | line | % | 500 | 0,30 | |||||||

gpsfig1 | column | % | 500 | 0,25 | |||||||

gpsfig2 | column,column,point | Contiuation rates %|LTP all adults$3 | 0, | ||||||||

gpsfig18a | distribution | Estimated prevalence (%) | 0 | ||||||||

gpsfig18b | distribution | Estimated prevalence (%) | 0 | ||||||||

gpsfig20 | column | % | 600 | 0,20 | |||||||

dlofig2 | stackedBar | % | 600 | ||||||||

dlofig3 | line | Index (2006 = 100) | 68 | ||||||||

dlofig3$ | pie | 1 135 701 reports (2011) | 30 | ||||||||

dlofig4 | line | Index (2006 = 100) | 68 | ||||||||

dlofig4$ | pie | 915 541 reports (2011) | 30 | ||||||||

dlofig5 | line | Index (2006 = 100) | 68 | ||||||||

dlofig5$ | pie | 179 418 reports (2011) | 30 | ||||||||

drdfig12a | scatter | Ratio between DRD in 2003 and 2000 | Number of DRD in 2000 | 1 | |||||||

drdfig12b | scatter | Ratio between DRD in 2010/11 and 2003 | Number of DRD in 2003 | 1 | |||||||

hsrfig2 | stackedColumn | Clients in substitution treatment | |||||||||

dlofig1 | line | Index (2006 = 100) | 60,180 | ||||||||

drdfig1 | column | Country and total number of DRD | 600 | ||||||||

drdfig2 | column | Proportion of DRD under the age of 25 (%) | 600 | ||||||||

drdfig3 | line | Mean age in years | |||||||||

drdfig4 | line | Mean age in years | |||||||||

drdfig5a | line | Index (1990 = 100) | |||||||||

drdfig5b | line | Index (1996 = 100) | |||||||||

drdfig6 | line | Index (1990 = 100 %) | 80,160 | ||||||||

drdfig7a | column | Mortality rate per million | |||||||||

drdfig7b | column,point | Rate per million | |||||||||

drdfig8 | line | Index (1985 = 100 %) | 50,650 | ||||||||

drdfig9a | line | % | 0,70 | ||||||||

drdfig9b | line | % | |||||||||

drdfig9c | line | % | |||||||||

drdfig10 | column | Mean age in years | 500 | ||||||||

drdfig11a | line | Index | 0,300 | ||||||||

drdfig11b | line | Index | |||||||||

drdfig11c | line | Index | |||||||||

drdfig13a | line | Number of cases | |||||||||

drdfig13b | line | Number of cases | |||||||||

eyefig1a | line | ||||||||||

eyefig1b | line | ||||||||||

eyefig1c | line | 0, | |||||||||

eyefig1d | line | % | 45 | 800 | |||||||

eyefig1d$ | line | % | 45 | 800 | |||||||

gpsfig3 | column | % | 500 | ||||||||

gpsfig4b | line | % | |||||||||

gpsfig5 | column | % | |||||||||

gpsfig6 | column | % | |||||||||

gpsfig7 | column | % | |||||||||

gpsfig8a | line | % | 0, | ||||||||

gpsfig8b | line | % | 0, | ||||||||

gpsfig9a | column | % | |||||||||

gpsfig9b | column | % | |||||||||

gpsfig10 | line | % | |||||||||

gpsfig11 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||

gpsfig12a | line | % | 0, | ||||||||

gpsfig12b | line | % | 0, | ||||||||

gpsfig13 | column,column,point | % | |||||||||

gpsfig14a | line | % | 0, | ||||||||

gpsfig14b | line | % | 0, | ||||||||

gpsfig15 | column | % | |||||||||

gpsfig16 | column,column,point | Continuation rates (%)|LTP All adults$3 | 0, | ||||||||

gpsfig17 | column | % | |||||||||

gpsfig21a | line | % | 0, | ||||||||

gpsfig21b | line | % | 0, | ||||||||

gpsfig22 | column,column,point | Continuation rates (%)| LTP All adults$3 | |||||||||

gpsfig23a | line | % | |||||||||

gpsfig23b | line | % | |||||||||

gpsfig23c | line | % | |||||||||

gpsfig23d | line | % | 0, | ||||||||

gpsfig23e | line | % | 0, | ||||||||

hsrfig4 | pie | % of prison population in OST | 30 | ||||||||

inffig1a | line | New AIDS cases per million population | 700 | 0, | |||||||

inffig1b | line | New AIDS cases per million population | 700 | 0, | |||||||

inffig2a | line | Cases per million population | 0, | ||||||||

inffig2b | line | Cases per million population | 0, | ||||||||

inffig2c | line | Cases per million population | |||||||||

inffig2d | line | Cases per million population | |||||||||

inffig3a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig3b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig3c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig6a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig6b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig6c | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig9a | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

inffig9b | distribution | % | 0, | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

pppfig1 | line | Index (2005 = 100) | |||||||||

pppfig2 | line | Index (2005 = 100) | |||||||||

tdifig1a | line | % | |||||||||

tdifig1b | line | ||||||||||

tdifig2a | pie | 30 | |||||||||

tdifig2b | pie | 50 | |||||||||

tdifig3a | line | % | |||||||||

tdifig3b | line | ||||||||||

tdifig7 | line | % | 60 | 0, | |||||||

tdifig7$ | stackedColumn | Numbers | 38 | 0,50000 | |||||||

hsrfig1b | stackedColumn | % | |||||||||

Distirbuted points with specific markers and colours | inffig6a | distribution | % | National;Subnational|square;rgba(0,0,0,0.8);triangle;rgba(0,0,255,0.8) | |||||||

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

EMCDDA

Praça Europa 1, Cais do Sodré

1249-289 Lisbon

Portugal

Tel. (351) 211 21 02 00

Fax (351) 218 13 17 11

Page last updated: Friday, 26 April 2013